Chiara M A Cefalo, Mariangela Rubino, Teresa Vanessa Fiorentino, Velia Cassano, Gaia Chiara Mannino, Alessia Riccio, Elena Succurro, Maria Perticone, Angela Sciacqua, Francesco Andreozzi, Giorgio Sesti
{"title":"低胰岛素样生长因子-1水平与老年人心肌机械能量效率有关。","authors":"Chiara M A Cefalo, Mariangela Rubino, Teresa Vanessa Fiorentino, Velia Cassano, Gaia Chiara Mannino, Alessia Riccio, Elena Succurro, Maria Perticone, Angela Sciacqua, Francesco Andreozzi, Giorgio Sesti","doi":"10.1210/clinem/dgaf209","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>Altered myocardial mechano-energetic efficiency (MEE) is a substantial predictor of cardiovascular events and heart failure. Among the potential pathophysiological factors underlying MEE impairment, insulin-like growth factor 1 (IGF-1) may be a plausible candidate due to its role in the cardiovascular system.</p><p><strong>Objective: </strong>This study aimed to analyze the relationship between plasma IGF-1 concentrations and myocardial MEE in a cohort of individuals older than 65 years, participating in the CATAnzaro MEtabolic RIsk factors (CATAMERI) study.</p><p><strong>Methods: </strong>Myocardial MEE per gram of left ventricular mass (MEEi) was measured in 490 older participants with a broad spectrum of glucose tolerance using echocardiography.</p><p><strong>Results: </strong>IGF-1 levels were positively associated with myocardial MEEi (r = 0.200; P < .001). Individuals in the highest tertile (tertile 3) of IGF-1 showed significantly lower heart rate and myocardial oxygen consumption, alongside a significant increase in myocardial MEEi compared to those in the lowest tertile. In multivariate linear regression analysis, IGF-1 levels were identified as the major determinant of MEEi, independently of well-established cardiometabolic risk factors.</p><p><strong>Conclusion: </strong>These findings suggest that low circulating IGF-1 levels are associated with depressed myocardial MEEi in older individuals. This highlights the potential importance of monitoring IGF-1 in clinical evaluations to assess cardiovascular health.</p>","PeriodicalId":50238,"journal":{"name":"Journal of Clinical Endocrinology & Metabolism","volume":" ","pages":"e4111-e4118"},"PeriodicalIF":5.1000,"publicationDate":"2025-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Low Insulin-Like Growth Factor-1 Levels Are Associated With Myocardial Mechano-Energetic Efficiency in Older Individuals.\",\"authors\":\"Chiara M A Cefalo, Mariangela Rubino, Teresa Vanessa Fiorentino, Velia Cassano, Gaia Chiara Mannino, Alessia Riccio, Elena Succurro, Maria Perticone, Angela Sciacqua, Francesco Andreozzi, Giorgio Sesti\",\"doi\":\"10.1210/clinem/dgaf209\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Context: </strong>Altered myocardial mechano-energetic efficiency (MEE) is a substantial predictor of cardiovascular events and heart failure. Among the potential pathophysiological factors underlying MEE impairment, insulin-like growth factor 1 (IGF-1) may be a plausible candidate due to its role in the cardiovascular system.</p><p><strong>Objective: </strong>This study aimed to analyze the relationship between plasma IGF-1 concentrations and myocardial MEE in a cohort of individuals older than 65 years, participating in the CATAnzaro MEtabolic RIsk factors (CATAMERI) study.</p><p><strong>Methods: </strong>Myocardial MEE per gram of left ventricular mass (MEEi) was measured in 490 older participants with a broad spectrum of glucose tolerance using echocardiography.</p><p><strong>Results: </strong>IGF-1 levels were positively associated with myocardial MEEi (r = 0.200; P < .001). Individuals in the highest tertile (tertile 3) of IGF-1 showed significantly lower heart rate and myocardial oxygen consumption, alongside a significant increase in myocardial MEEi compared to those in the lowest tertile. In multivariate linear regression analysis, IGF-1 levels were identified as the major determinant of MEEi, independently of well-established cardiometabolic risk factors.</p><p><strong>Conclusion: </strong>These findings suggest that low circulating IGF-1 levels are associated with depressed myocardial MEEi in older individuals. This highlights the potential importance of monitoring IGF-1 in clinical evaluations to assess cardiovascular health.</p>\",\"PeriodicalId\":50238,\"journal\":{\"name\":\"Journal of Clinical Endocrinology & Metabolism\",\"volume\":\" \",\"pages\":\"e4111-e4118\"},\"PeriodicalIF\":5.1000,\"publicationDate\":\"2025-11-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Endocrinology & Metabolism\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1210/clinem/dgaf209\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Endocrinology & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1210/clinem/dgaf209","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
背景和目的:心肌机械能量效率(MEE)的改变是心血管事件和心力衰竭的重要预测因子。在MEE损伤的潜在病理生理因素中,胰岛素样生长因子-1 (IGF-1)可能是一个合理的候选因素,因为它在心血管系统中的作用。本研究旨在分析参与CATAnzaro代谢危险因素(CATAMERI)研究的一组年龄在50 ~ 65岁的老年人血浆IGF-1浓度与心肌MEE之间的关系。方法:采用超声心动图测量490例具有广谱糖耐量的老年受试者每克左心室质量(mei)的心肌MEE。结果:IGF-1水平与心肌MEEi呈正相关(r = 0.200, P < 0.001)。与IGF-1水平最低的个体相比,IGF-1水平最高的个体表现出明显较低的心率和心肌耗氧量,同时心肌MEEi水平也显著升高。在多元线性回归分析中,IGF-1水平被确定为MEEi的主要决定因素,独立于已建立的心脏代谢危险因素。结论:这些发现表明,低循环IGF-1水平与老年人心肌mei下降有关。这突出了监测IGF-1在临床评估中评估心血管健康的潜在重要性。
Low Insulin-Like Growth Factor-1 Levels Are Associated With Myocardial Mechano-Energetic Efficiency in Older Individuals.
Context: Altered myocardial mechano-energetic efficiency (MEE) is a substantial predictor of cardiovascular events and heart failure. Among the potential pathophysiological factors underlying MEE impairment, insulin-like growth factor 1 (IGF-1) may be a plausible candidate due to its role in the cardiovascular system.
Objective: This study aimed to analyze the relationship between plasma IGF-1 concentrations and myocardial MEE in a cohort of individuals older than 65 years, participating in the CATAnzaro MEtabolic RIsk factors (CATAMERI) study.
Methods: Myocardial MEE per gram of left ventricular mass (MEEi) was measured in 490 older participants with a broad spectrum of glucose tolerance using echocardiography.
Results: IGF-1 levels were positively associated with myocardial MEEi (r = 0.200; P < .001). Individuals in the highest tertile (tertile 3) of IGF-1 showed significantly lower heart rate and myocardial oxygen consumption, alongside a significant increase in myocardial MEEi compared to those in the lowest tertile. In multivariate linear regression analysis, IGF-1 levels were identified as the major determinant of MEEi, independently of well-established cardiometabolic risk factors.
Conclusion: These findings suggest that low circulating IGF-1 levels are associated with depressed myocardial MEEi in older individuals. This highlights the potential importance of monitoring IGF-1 in clinical evaluations to assess cardiovascular health.
期刊介绍:
The Journal of Clinical Endocrinology & Metabolism is the world"s leading peer-reviewed journal for endocrine clinical research and cutting edge clinical practice reviews. Each issue provides the latest in-depth coverage of new developments enhancing our understanding, diagnosis and treatment of endocrine and metabolic disorders. Regular features of special interest to endocrine consultants include clinical trials, clinical reviews, clinical practice guidelines, case seminars, and controversies in clinical endocrinology, as well as original reports of the most important advances in patient-oriented endocrine and metabolic research. According to the latest Thomson Reuters Journal Citation Report, JCE&M articles were cited 64,185 times in 2008.